1. Home
  2. MRSN vs TBHC Comparison

MRSN vs TBHC Comparison

Compare MRSN & TBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • TBHC
  • Stock Information
  • Founded
  • MRSN 2001
  • TBHC 1966
  • Country
  • MRSN United States
  • TBHC United States
  • Employees
  • MRSN N/A
  • TBHC N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • TBHC Other Specialty Stores
  • Sector
  • MRSN Health Care
  • TBHC Consumer Discretionary
  • Exchange
  • MRSN Nasdaq
  • TBHC Nasdaq
  • Market Cap
  • MRSN 37.0M
  • TBHC 40.4M
  • IPO Year
  • MRSN 2017
  • TBHC N/A
  • Fundamental
  • Price
  • MRSN $8.07
  • TBHC $1.69
  • Analyst Decision
  • MRSN Strong Buy
  • TBHC
  • Analyst Count
  • MRSN 3
  • TBHC 0
  • Target Price
  • MRSN $33.00
  • TBHC N/A
  • AVG Volume (30 Days)
  • MRSN 41.5K
  • TBHC 294.6K
  • Earning Date
  • MRSN 11-12-2025
  • TBHC 09-16-2025
  • Dividend Yield
  • MRSN N/A
  • TBHC N/A
  • EPS Growth
  • MRSN N/A
  • TBHC N/A
  • EPS
  • MRSN N/A
  • TBHC N/A
  • Revenue
  • MRSN $34,769,000.00
  • TBHC $420,610,000.00
  • Revenue This Year
  • MRSN N/A
  • TBHC N/A
  • Revenue Next Year
  • MRSN N/A
  • TBHC N/A
  • P/E Ratio
  • MRSN N/A
  • TBHC N/A
  • Revenue Growth
  • MRSN 16.14
  • TBHC N/A
  • 52 Week Low
  • MRSN $5.21
  • TBHC $1.20
  • 52 Week High
  • MRSN $70.75
  • TBHC $2.40
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 61.29
  • TBHC 48.67
  • Support Level
  • MRSN $7.63
  • TBHC $1.55
  • Resistance Level
  • MRSN $8.35
  • TBHC $1.88
  • Average True Range (ATR)
  • MRSN 0.39
  • TBHC 0.13
  • MACD
  • MRSN 0.01
  • TBHC -0.02
  • Stochastic Oscillator
  • MRSN 72.97
  • TBHC 29.55

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About TBHC The Brand House Collective Inc.

The Brand House Collective Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.

Share on Social Networks: